TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pro Health Pharma Sweden AB
Closing information (x1000 NOK)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
25,368
|
21,865 | |
| Financial expenses |
145
|
170 | |
| Earnings before taxes |
3,589
|
671 | |
| EBITDA |
4,225
|
841 | |
| Total assets |
13,214
|
16,626 | |
| Current assets |
10,933
|
13,879 | |
| Current liabilities |
3,238
|
6,393 | |
| Equity capital |
9,557
|
10,028 | |
| - share capital |
103
|
101 | |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
72.3%
|
60.3% | |
| Turnover per employee |
8,456
|
7,288 | |
| Profit as a percentage of turnover |
14.1%
|
3.1% | |
| Return on assets (ROA) |
28.3%
|
5.1% | |
| Current ratio |
337.6%
|
217.1% | |
| Return on equity (ROE) |
37.6%
|
6.7% | |
| Change turnover |
3,108
|
2,218 | |
| Change turnover % |
8%
|
14%
|
11% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.